These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 27664297)

  • 21. Efforts of subthalamic nucleus deep brain stimulation on cognitive spectrum: From explicit to implicit changes in the patients with Parkinson's disease for 1 year.
    You Z; Wu YY; Wu R; Xu ZX; Wu X; Wang XP
    CNS Neurosci Ther; 2020 Sep; 26(9):972-980. PubMed ID: 32436660
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sensorimotor subthalamic stimulation restores risk-reward trade-off in Parkinson's disease.
    Irmen F; Horn A; Meder D; Neumann WJ; Plettig P; Schneider GH; Siebner HR; Kühn AA
    Mov Disord; 2019 Mar; 34(3):366-376. PubMed ID: 30485537
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Subthalamic Nucleus Deep Brain Stimulation Modulate Catecholamine Levels with Significant Relations to Clinical Outcome after Surgery in Patients with Parkinson's Disease.
    Yamamoto T; Uchiyama T; Higuchi Y; Asahina M; Hirano S; Yamanaka Y; Kuwabara S
    PLoS One; 2015; 10(9):e0138462. PubMed ID: 26394059
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Subthalamic nucleus versus globus pallidus bilateral deep brain stimulation for advanced Parkinson's disease (NSTAPS study): a randomised controlled trial.
    Odekerken VJ; van Laar T; Staal MJ; Mosch A; Hoffmann CF; Nijssen PC; Beute GN; van Vugt JP; Lenders MW; Contarino MF; Mink MS; Bour LJ; van den Munckhof P; Schmand BA; de Haan RJ; Schuurman PR; de Bie RM
    Lancet Neurol; 2013 Jan; 12(1):37-44. PubMed ID: 23168021
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neuropsychological and psychiatric changes after deep brain stimulation for Parkinson's disease: a randomised, multicentre study.
    Witt K; Daniels C; Reiff J; Krack P; Volkmann J; Pinsker MO; Krause M; Tronnier V; Kloss M; Schnitzler A; Wojtecki L; Bötzel K; Danek A; Hilker R; Sturm V; Kupsch A; Karner E; Deuschl G
    Lancet Neurol; 2008 Jul; 7(7):605-14. PubMed ID: 18538636
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Longterm outcome of cognition, affective state, and quality of life following subthalamic deep brain stimulation in Parkinson's disease.
    Gruber D; Calmbach L; Kühn AA; Krause P; Kopp UA; Schneider GH; Kupsch A
    J Neural Transm (Vienna); 2019 Mar; 126(3):309-318. PubMed ID: 30684055
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of deep brain stimulation of the subthalamic nucleus on freezing of gait in Parkinson's disease: a prospective controlled study.
    Vercruysse S; Vandenberghe W; Münks L; Nuttin B; Devos H; Nieuwboer A
    J Neurol Neurosurg Psychiatry; 2014 Aug; 85(8):871-7. PubMed ID: 24396010
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Improving outcomes of subthalamic nucleus deep brain stimulation in Parkinson's disease.
    Bari AA; Fasano A; Munhoz RP; Lozano AM
    Expert Rev Neurother; 2015 Oct; 15(10):1151-60. PubMed ID: 26377740
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of subthalamic nucleus stimulation and levodopa on decision-making in Parkinson's disease.
    Atkinson-Clement C; Cavazzini É; Zénon A; Witjas T; Fluchère F; Azulay JP; Baunez C; Eusebio A
    Mov Disord; 2019 Mar; 34(3):377-385. PubMed ID: 30681186
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Parkinson's disease, the subthalamic nucleus, inhibition, and impulsivity.
    Jahanshahi M; Obeso I; Baunez C; Alegre M; Krack P
    Mov Disord; 2015 Feb; 30(2):128-40. PubMed ID: 25297382
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of stimulation of the subthalamic nucleus on naming and reading nouns and verbs in Parkinson's disease.
    Silveri MC; Ciccarelli N; Baldonero E; Piano C; Zinno M; Soleti F; Bentivoglio AR; Albanese A; Daniele A
    Neuropsychologia; 2012 Jul; 50(8):1980-9. PubMed ID: 22575085
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Decision-making under risk is improved by both dopaminergic medication and subthalamic stimulation in Parkinson's disease.
    Boller JK; Barbe MT; Pauls KA; Reck C; Brand M; Maier F; Fink GR; Timmermann L; Kalbe E
    Exp Neurol; 2014 Apr; 254():70-7. PubMed ID: 24444545
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effects of bilateral subthalamic nucleus deep brain stimulation (STN DBS) on cognition in Parkinson disease.
    Heo JH; Lee KM; Paek SH; Kim MJ; Lee JY; Kim JY; Cho SY; Lim YH; Kim MR; Jeong SY; Jeon BS
    J Neurol Sci; 2008 Oct; 273(1-2):19-24. PubMed ID: 18640690
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Single electrode and multiple electrode guided electrical stimulation of the subthalamic nucleus in advanced Parkinson's disease.
    Temel Y; Wilbrink P; Duits A; Boon P; Tromp S; Ackermans L; van Kranen-Mastenbroek V; Weber W; Visser-Vandewalle V
    Neurosurgery; 2007 Nov; 61(5 Suppl 2):346-55; discussion 355-7. PubMed ID: 18091250
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The structural connectivity of subthalamic deep brain stimulation correlates with impulsivity in Parkinson's disease.
    Mosley PE; Paliwal S; Robinson K; Coyne T; Silburn P; Tittgemeyer M; Stephan KE; Perry A; Breakspear M
    Brain; 2020 Jul; 143(7):2235-2254. PubMed ID: 32568370
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neuropsychological changes following deep brain stimulation surgery for Parkinson's disease: comparisons of treatment at pallidal and subthalamic targets versus best medical therapy.
    Rothlind JC; York MK; Carlson K; Luo P; Marks WJ; Weaver FM; Stern M; Follett K; Reda D;
    J Neurol Neurosurg Psychiatry; 2015 Jun; 86(6):622-9. PubMed ID: 25185211
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neuropsychological effects of deep brain stimulation in subjects with early stage Parkinson's disease in a randomized clinical trial.
    Tramontana MG; Molinari AL; Konrad PE; Davis TL; Wylie SA; Neimat JS; May AT; Phibbs FT; Hedera P; Gill CE; Salomon RM; Wang L; Song Y; Charles D
    J Parkinsons Dis; 2015; 5(1):151-63. PubMed ID: 25613351
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Exhaustive, one-year follow-up of subthalamic nucleus deep brain stimulation in a large, single-center cohort of parkinsonian patients.
    Tir M; Devos D; Blond S; Touzet G; Reyns N; Duhamel A; Cottencin O; Dujardin K; Cassim F; Destée A; Defebvre L; Krystkowiak P
    Neurosurgery; 2007 Aug; 61(2):297-304; discussion 304-5. PubMed ID: 17762742
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Stimulation of the subthalamic nucleus and impulsivity: release your horses.
    Ballanger B; van Eimeren T; Moro E; Lozano AM; Hamani C; Boulinguez P; Pellecchia G; Houle S; Poon YY; Lang AE; Strafella AP
    Ann Neurol; 2009 Dec; 66(6):817-24. PubMed ID: 20035509
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Three-dimensional SPACE fluid-attenuated inversion recovery at 3 T to improve subthalamic nucleus lead placement for deep brain stimulation in Parkinson's disease: from preclinical to clinical studies.
    Senova S; Hosomi K; Gurruchaga JM; Gouello G; Ouerchefani N; Beaugendre Y; Lepetit H; Lefaucheur JP; Badin RA; Dauguet J; Jan C; Hantraye P; Brugières P; Palfi S
    J Neurosurg; 2016 Aug; 125(2):472-80. PubMed ID: 26745490
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.